MyEClinic
MyEClinic
Health Dictionary Find a Doctor

Mini-BEAM regimen

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aparna Vuppala, M.B.B.S. [2]

Synonyms and keywords: BCNU-Etoposide-AraC-Melphalan Regimen; Mini-BEAM Regimen

Overview

Overview

Mini-BEAM regimen refers to a dose-reduced variant of the BEAM conditioning regimen used in the transplant setting, consisting of carmustine (bis-chloroethylnitrosourea, BCNU), etoposide, cytarabine (AraC), and melphalan and used for the treatment of relapsed or refractory Hodgkin’s lymphoma.[1][2]

Regimen

Regimen

BCarmustine (BCNU)

EEtoposide

ACytarabine (AraC)

MMelphalan

Indications

Indications

References

References

  1. ↑ “NCI Thesaurus”.
  2. ↑ 2.0 2.1 Colwill R, Crump M, Couture F, Danish R, Stewart AK, Sutton DM; et al. (1995). “Mini-BEAM as salvage therapy for relapsed or refractory Hodgkin’s disease before intensive therapy and autologous bone marrow transplantation”. J Clin Oncol. 13 (2): 396–402. PMID 7844600.

Looking for the patient version?

Back to the patient-friendly article

Imprint

Privacy Policy

Terms and Conditions

© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH